Our CEO, Luc Mongeau, will participate in the 46th Annual Canaccord Genuity Growth Conference on August 11th at 12:00 p.m. ET.
For live webcast link and more information: https://t.co/uI9EbZPkre
$WEED — Canopy Growth Corporation | FY2026 & Q4 Results
A global cannabis company (Tweed, 7ACRES, Storz & Bickel) pushing toward profitability
📊 FY2026 Highlights:
• Net revenue: $284.6M, +6% YoY
• Cannabis net revenue: $213.9M, +15% YoY
• Gross margin: 24% (28% adjusted)
• Net loss: $(262.9)M — heavily non-cash (impairments + other expense)
• Adjusted EBITDA loss: $(20.2)M, improving
⚡ Q4 FY2026:
• Net revenue: $71.2M, +10% YoY
• Canada medical cannabis +27%; international cannabis +68%
• Adjusted EBITDA loss narrowed to $(6.3)M, +32% YoY
• ~$10.7M of inventory charges weighed on reported gross margin (12%)
🤝 Strategic:
• Completed the MTL Cannabis acquisition — now Canada's leading medical cannabis company by revenue
• Cash jumped to $364.7M (from $113.8M) after equity & debt raises
🔮 Outlook:
• Guiding to positive Adjusted EBITDA during FY2027
Canopy's FY2026 is a classic late-stage turnaround read: top-line is growing again, the adjusted EBITDA loss is shrinking, and the MTL deal cements a medical-cannabis lead. but reported losses are still huge (mostly non-cash impairments and fair-value charges), gross margins compressed, and free cash flow stayed negative at $(69.1)M. the FY2027 positive-EBITDA guide is the bar to watch.
Full analysis:
https://t.co/F1XUnEKlPL
#TSX #CanadianStocks #Cannabis #Turnaround #MedicalCannabis
▶️ "2026 was a reset for Canopy Growth. We adjusted the cost base, we elevated the quality of our manufacturing, we recapitalized the organization, and we acquired MTL."
— Luc Mongeau, CEO of @CanopyGrowth $CGC
🎦 WATCH: https://t.co/w4ai4ChWuf
🌿 ETFs: 🌎 $YOLO 🇺🇸 $MSOS
Canopy Growth Corp $CGC has executed a massive financial recapitalization, successfully eliminating going-concern risks to achieve a solid net cash position. The business is seeing robust momentum in high-margin segments, driven by the rapid integration of MTL Cannabis in Canada and surging international medical sales fueled by German regulatory easing. Despite these operational victories, the company's valuation remains highly speculative due to persistent net losses and a major financial restatement that exposed ineffective internal controls. With the stock trading near historical lows and relying heavily on unconsolidated United States assets for future upside, can management successfully resolve its governance hurdles to finally deliver sustainable profitability?
Canopy Growth Reports Fourth Quarter and Fiscal Year 2026 Financial Results; Delivers Q4 FY2026 Net Revenue Growth of 27% in Canada Medical and 68% in International Markets Cannabis
Read more: https://t.co/XfKFoqiKgt
Claybourne’s Frosted Flyers won 'Best Infused Pre-Roll' at the 2026 Grow Up Awards. Today, we’re building on that momentum launching three new 8-pack variety formats and first bundle pack from one of Canada’s fastest growing cannabis brands.
Full details: https://t.co/hCVY5i6kdZ
MTL is live in Germany 🇩🇪
Our premium MTL genetics just hit Europe’s largest medical cannabis market. Pablo's Revenge, Dante’z Inferno, and Frost’d Flakes are now available to German medical patients under the relaunched Tweed brand.
Learn more: https://t.co/TPDpGKKIN5
@BernieSanders In 2022, you voted in favor of sending $40 billion in emergency funding to Ukraine. Your past actions indicate you do in fact support endless wars.
New Map of Canada 🇨🇦 after tomorrow this country will never be the same again!! We are sick of Quebec and Ontario dictating everything we do
#rigged#CanadaElections2025
BREAKING: Premier Smith unveils major updates to the Citizen Initiative Act. Now, only 177,000 signatures are needed to trigger a referendum on Alberta independence, down from 600,000. Plus, the signature collection period extends from 90 to 120 days. #ABPolitics #AlbertaIndependence